Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03910361 Completed - Clinical trials for Non-Alcoholic Fatty Liver Disease

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Start date: April 12, 2019
Phase: Phase 4
Study type: Interventional

A multicenter, double-blind, active-controlled, randomized, parallel, phase IV clinical trial to evaluate the efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver diseases

NCT ID: NCT03910257 Completed - Clinical trials for Children Who Registered on the Selected Public Kindergarten and Agree to Follow the Study Assigned by Their Parents and Teacher

Nutrition Education Module for Preschooler Children

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This study evaluates the knowledge of preschooler children before and after intervention of nutrition education using nutrition education module for preschooler children. The teachers will be given training regarding the module and deliver it in the class during the intervention.

NCT ID: NCT03910244 Completed - Clinical trials for Telangiectasia, Hereditary Hemorrhagic

Pomalidomide for the Treatment of Bleeding in HHT

PATH-HHT
Start date: October 17, 2019
Phase: Phase 2
Study type: Interventional

This is a Phase II placebo-controlled double-blind study of pomalidomide in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate to severe epistaxis who have anemia and/or require parenteral iron infusions or blood transfusions. A total of 159 patients will be randomized 2:1 to treatment with oral pomalidomide or matching placebo for 24 weeks. Mean change from baseline to 24 weeks in the Epistaxis Severity Score (ESS) will be compared between treatment groups to determine pomalidomide efficacy.

NCT ID: NCT03910114 Completed - Clinical trials for Magnetic Resonance Imaging Contrast Agents

Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography

Start date: July 1, 1990
Phase:
Study type: Observational

Rationale: Dotarem provides superior enhancement characteristics compared to other GBCA in fMRU Specific Aims: Compare enhancement characteristics of Dotarem to other GBCAs in the kidneys used in fMRU Primary Objectives: Review functional analysis curves and data of fMRU studies and determine enhancement characteristics in the kidneys of the three GBCAs (Dotarem, Gadovist, Magnevist)

NCT ID: NCT03909854 Completed - Respiratory Failure Clinical Trials

Pragmatic Investigation of Volume Targeted Ventilation-1

PIVOT-1
Start date: September 9, 2019
Phase: N/A
Study type: Interventional

This proposal will test the feasibility of implementing an assist volume control ventilation protocol in patients receiving mechanical ventilation in the medical intensive care unit. The trial will consist of a before-and-after trial design of block assignment to either adaptive pressure control (baseline) or assist volume control . This is a feasibility study looking at the management of patients in the ventilator.

NCT ID: NCT03909841 Completed - Diabetes Mellitus Clinical Trials

Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition

Start date: June 1, 2017
Phase:
Study type: Observational

This study was set out 1) Evaluate the impact of Diabetic Peripheral Neuropathy (DPN) and DPN-P (Diabetic Peripheral Neuropathic Pain) on the overall Quality of Life (QoL) in elderly with Diabetic Mellitus (DM) and 2) Evaluate the association between cognition impairments and DM in the elderly, and the contributions of DPN and/or DPN-P

NCT ID: NCT03909425 Completed - Clinical trials for Neovascular Age-related Macular Degeneration

Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography

DANA
Start date: September 2, 2019
Phase:
Study type: Observational

The purpose of this study is to be able to describe optical coherence angiography (OCTA) patterns of disease activity and quiescence in eyes that have received treatment. The target population group is patients that have neovascular age-related macular degeneration and have had treatment with aflibercept for this condition. This is a single-site study and does not involve any masking or treatment allocation.

NCT ID: NCT03908424 Completed - Clinical trials for Parturient Who Gave Informed Consent to Participation in the Study

Chronic Headache and Chronic Backache Following Unintentional Dural Puncture at Delivery Room.

Start date: May 1, 2019
Phase:
Study type: Observational

he study is a telephone questionnaire. The study will include 400 women, 100 in each group. OBJECTIVE: To investigate the prevalence of chronic and chronic back pain following PDPH accidental dural puncture during epidyral analgesia for delivery. 1. Parturients who gave birth to a normal birth and did not receive epidural anesthesia. 2. Parturients who gave birth to a normal birth with epidural anesthesia without an unintentional dural puncture. 3. Parturients who gave birth to a normal birth with epidural anesthesia and had an unintentional dural puncture, these women were treated conservatively. 4. Parturients who had a normal birth with epidural anesthesia and had an unintentional dural puncture and were treated with a blood patch following PDPH.

NCT ID: NCT03907774 Completed - Clinical trials for Myeloproliferative Neoplasm, Unclassifiable

MPN Podcast Pilot Study

Start date: June 1, 2019
Phase:
Study type: Observational

Enrolled MPN patients will participate in a podcast intervention via a smartphone app. They will listen to 60 minutes per week of podcasts through this app, which consist of cancer-related health education material. Participants have the option to listen to additional podcasts beyond the 60-minute weekly prescription if they desire. Participation will be tracked through self-report logs. In addition, questionnaires will be administered at baseline, midpoint (week 6), and post-intervention (week 12), which ask about demographics, health information, and satisfaction. The hypothesis is that the smartphone app is feasible for delivering home-based health education podcasts to MPN patients.

NCT ID: NCT03907761 Completed - Clinical trials for Recurrent Laryngeal Nerve Injuries

Hydrodissection of Recurrent Laryngeal Nerve: Case Series

Start date: February 1, 2016
Phase:
Study type: Observational

This study evaluates the hydrodissection technique in recurrent laryngeal nerve (RLN) dissection in thyroid surgeries. In this study hydrodissection of RLN was performed routinely in thyroid surgeries.